Diagnostic Utility of Triglyceride-Glucose Index in Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study on Lean Population
Tuo Han,Ying Li,Jing Xiao,Hong Gong,Fuxue Deng,Wei Jiang,Congxia Wang,Fangyao Chen,Chunyan Zhang,Jie Deng,Yan Zhang
DOI: https://doi.org/10.2147/dmso.s469398
2024-09-22
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Tuo Han, 1, &ast Ying Li, 1, &ast Jing Xiao, 1, &ast Hong Gong, 2 Fuxue Deng, 1 Wei Jiang, 1 Congxia Wang, 1 Fangyao Chen, 3 Chunyan Zhang, 1 Jie Deng, 1 Yan Zhang 1 1 Department of Cardiology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, People's Republic of China; 2 Department of Health Management, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710004, People's Republic of China; 3 Department of Epidemiology and Health Statistics, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, 710061, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yan Zhang; Jie Deng, Email ; Background: Approximately 10– 20% of individuals with non-alcoholic fatty liver disease (NAFLD) are lean, and the underlying pathophysiology is not yet understood. This study aims to explore the characteristics and the diagnostic value of triglyceride-glucose index (TyG) in early diagnosis of lean NAFLD. Methods: 99 patients with lean NAFLD and 1891 healthy controls were included in the health examination. The characteristics were compared between groups. Restricted cubic spline was utilized to analyze the relationship between TyG index and the risk of lean NAFLD. Logistic regression and receiver operating curve (ROC) were applied to explore the diagnostic value of TyG index for lean NAFLD. Results: Overall, 99 (4.97%) patients had lean NAFLD. Patients with lean NAFLD have significant abnormal glycolipid metabolism and higher TyG index. Restriction cube spline analysis showed a significant dose-response relationship between the TyG index and risk of lean NAFLD. After adjusting for confounders, the relationship remained and the risk of developing lean NAFLD increased 2.99 times for per unit increase of TyG index (95% CI: 1.94, 4.67, P < 0.001). The areas under the ROC of the TyG index for lean NAFLD detection were 0.851 (0.815 to 0.886). Conclusion: The TyG index is positively associated with the risk of developing lean NAFLD and could be a useful marker for early diagnosis of lean NAFLD. Keywords: lean non-alcoholic fatty liver disease, triglyceride-glucose index, insulin resistance Non-alcoholic fatty liver disease (NAFLD), also known as metabolic dysfunction-associated steatotic liver disease (MASLD), is currently the most common of chronic liver disease worldwide, affecting at least one in four adults worldwide. 1 Although NAFLD is closely related to abdominal obesity and visceral fat accumulation, up to 40% of patients are not obese and almost 20% of patients have a BMI in the normal range, the so-called "lean NAFLD". 2 It is estimated that the prevalence of lean NAFLD is about 4.1% worldwide, particularly in Asians and middle-aged people, the prevalence of lean NAFLD is higher. 3,4 Patients with NAFLD have a significantly increased risk of cardiovascular disease (CVD) and cardiovascular mortality. Based on data from the National Health and Nutrition Examination Survey (NHANES), NAFLD is associated with a 23% increased risk of CVD, even after accounting for demographic, disease history, and metabolic factors. 5 CVD is also the leading cause of death in NAFLD patients. Results from two large prospective cohort studies showed that the risk of cardiovascular death was two to three times higher in NAFLD patients than in healthy controls. 6,7 This is mainly attributed to the common abnormalities of glycolipid metabolism, insulin resistance, immune and systemic inflammation, neuroendocrine homeostasis imbalance, thrombosis activation, and overactivation of the renin-angiotensin system in NAFLD patients. 8 Previous studies have shown that lean NAFLD patients have fewer metabolic disorders than overweight or obese NAFLD patients and are less likely to develop diabetes, hypertension, abdominal obesity, and metabolic syndrome. 4,9 However, other studies have found that patients with advanced lean NAFLD have more severe liver fibrosis and higher cardiovascular and all-cause mortality. 10,11 The pathophysiology, prognosis and management of lean NAFLD have become the focus of attention and research. Insulin resistance (IR) refers to the reduced sensitivity of peripheral target organs or tissues to insulin, which is a central pathological mechanism in the development of NAFLD. Studies have shown that liver fat content of NAFLD patients is significantly positively correlated with fasting blood glucose and IR index HOMA-IR. 12,13 The hyperinsulinaemic-eug -Abstract Truncated-
endocrinology & metabolism